market. Read about the scientific challenges of producing value-added genetically modified plants and the process of satisfying regulatory concerns. Interestingly, Flavr Savr tomatoes did not fail in the market due to public resistance or poor sales, but rather due to management.s inexperience in the premium tomato business which left them unable to sell the tomatoes at a profit.

Global Hubs and Global Nodes of Biotechnology
Richard Seline and Yali Friedman
New Economy Strategies, 2006. http://www.Bioeconomy.org
This report is an international scan of biotechnology strategies, initiatives, and institutional capacity in 35 countries around the world. The emphasis of this report is on the regional incentives, research, infrastructure, and funding opportunities, to help facilitate regional development initiatives and infrastructure investment decisions.

The Golden Helix
Arthur Kornberg
University Science Books, 1996. ISBN: 0935702326
Nobel laureate Arthur Kornberg was originally skeptical of commercial biotechnology, insisting that academic labs were better equipped to research fundamental issues in biology. In this book, Kornberg details his involvement in the development of Alza, a drug delivery firm, and the growth of the biotechnology industry during this time. Countering his earlier sentiments, Kornberg concludes that industry, not academia, is where the most productive science takes place.

Term Sheets & Valuations
Alex Wilmerding
Aspatore Books, 2006. ISBN: 1587620685
An in-depth look at term sheets. In addition to a section-by-section view of a term sheet, valuations, and guidance, this book includes a sample term sheet with a description of each clause and a discussion of key negotiation points and red flags.

U.S. and Canadian Biotechnology VC Directory
BioAbility, LLC
http://www.bioworld.com/
This book is a straight-forward and comprehensive listing of VC firms investing in biotechnology.